In recent years, increasing research has revealed that tumor angiogenesis is a critical process in NSCLC progression, with vascular endothelial growth factor (VEGF) being a key mediator in this process (Lee et al., 2016; Jayakumar et al., 2018; Wu and Zhang, 2016). The gene discussed is VEGFA; the disease is neoplasm.